Form 4 for REGN Regeneron Pharmaceuticals
Accepted 2024-09-05 00:00:00 ET · period of report 2024-09-03 · accession 0001968202-24-000124 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2024-09-05 | 2024-09-03 | REGN | RYAN ARTHUR F | Dir | S - Sale | $1,178.68 | -100 | 17.7K | -0.6% | -$117.9K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-09-03 | S | D | 3 | $1,187.95 | 17,696 | D | — | — | (F8) Represents volume-weighted average price of sales of 3 shares of Company stock on September 3, 2024 at prices ranging from $1,187.86 to $1,187.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 3, 2024 at each separate price. |
| 2 | Common | Common Stock | 2024-09-03 | S | D | 4 | $1,188.55 | 17,692 | D | — | — | |
| 3 | Common | Common Stock | 2024-09-03 | S | D | 5 | $1,189.13 | 17,687 | D | — | — | (F9) Represents volume-weighted average price of sales of 5 shares of Company stock on September 3, 2024 at prices ranging from $1,189.04 to $1,189.50. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 3, 2024 at each separate price. |
| 4 | Common | Common Stock | 2024-09-03 | S | D | 1 | $1,190.00 | 17,686 | D | — | — | |
| 5 | Common | Common Stock | 2024-09-03 | S | D | 4 | $1,191.02 | 17,682 | D | — | — | |
| 6 | Common | Common Stock | 2024-09-03 | S | D | 4 | $1,166.52 | 17,778 | D | — | — | |
| 7 | Common | Common Stock | 2024-09-03 | S | D | 1 | $1,167.27 | 17,777 | D | — | — | |
| 8 | Common | Common Stock | 2024-09-03 | S | D | 4 | $1,168.99 | 17,773 | D | — | — | |
| 9 | Common | Common Stock | 2024-09-03 | S | D | 4 | $1,170.40 | 17,769 | D | — | — | |
| 10 | Common | Common Stock | 2024-09-03 | S | D | 16 | $1,172.75 | 17,753 | D | — | — | (F2) Represents volume-weighted average price of sales of 16 shares of Company stock on September 3, 2024 at prices ranging from $1,172.66 to $1,172.95. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 3, 2024 at each separate price. |
| 11 | Common | Common Stock | 2024-09-03 | S | D | 8 | $1,174.32 | 17,745 | D | — | — | (F3) Represents volume-weighted average price of sales of 8 shares of Company stock on September 3, 2024 at prices ranging from $1,174.14 to $1,174.49. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 3, 2024 at each separate price. |
| 12 | Common | Common Stock | 2024-09-03 | S | D | 8 | $1,175.66 | 17,737 | D | — | — | (F4) Represents volume-weighted average price of sales of 8 shares of Company stock on September 3, 2024 at prices ranging from $1,175.35 to $1,175.97. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 3, 2024 at each separate price. |
| 13 | Common | Common Stock | 2024-09-03 | S | D | 4 | $1,176.82 | 17,733 | D | — | — | |
| 14 | Common | Common Stock | 2024-09-03 | S | D | 5 | $1,186.19 | 17,699 | D | — | — | (F7) Represents volume-weighted average price of sales of 5 shares of Company stock on September 3, 2024 at prices ranging from $1,186.12 to $1,186.47. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 3, 2024 at each separate price. |
| 15 | Common | Common Stock | 2024-09-03 | S | D | 4 | $1,185.77 | 17,704 | D | — | — | |
| 16 | Common | Common Stock | 2024-09-03 | S | D | 1 | $1,184.26 | 17,708 | D | — | — | |
| 17 | Common | Common Stock | 2024-09-03 | S | D | 8 | $1,183.47 | 17,709 | D | — | — | (F6) Represents volume-weighted average price of sales of 8 shares of Company stock on September 3, 2024 at prices ranging from $1,183.39 to $1,183.54. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 3, 2024 at each separate price. |
| 18 | Common | Common Stock | 2024-09-03 | S | D | 8 | $1,179.62 | 17,717 | D | — | — | (F5) Represents volume-weighted average price of sales of 8 shares of Company stock on September 3, 2024 at prices ranging from $1,179.52 to $1,179.72. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 3, 2024 at each separate price. |
| 19 | Common | Common Stock | 2024-09-03 | S | D | 4 | $1,177.73 | 17,729 | D | — | — | |
| 20 | Common | Common Stock | 2024-09-03 | S | D | 4 | $1,178.69 | 17,725 | D | — | — |